Investing in the COVID-19 Response through the ACT-Accelerator: Long-Term Benefits

Overview

Investing in the work of ACT-Accelerator agencies will not only address the immediate COVID-19 pandemic but will have long-lasting outcomes. Alongside increasing access to the tools needed to end the pandemic, the partnership is helping countries to build laboratory capacity and enhance the cold chain, create and maintain oxygen systems, train healthcare workers, and pilot the roll-out of test and treat protocols in communities.

This document outlines key investments in the global COVID-19 response through the ACT Accelerator that will have long-term benefits.